Women’s health, cycle, and menopause
Oestrogen and progesterone influence colonic transit, visceral sensitivity, and immune signalling in the gut. The menstrual cycle therefore changes bowel habits in many people without any change in diet, constipation in the luteal phase, looser stools with menses, and bloating that tracks hormones more than FODMAP grams. Menopause and perimenopause add another layer: declining oestrogen associates with symptom flares in some IBS cohorts and alters microbiome composition in cross-sectional studies, association, not a hormone prescription tool.
A consumer microbiome report is a single timepoint. Unless collection-day cycle phase and contraceptive use are recorded (they usually are not), comparing “low diversity” to symptoms that swing weekly is a category error.
For pregnancy and infants: Pediatric and pregnancy microbiome interpretation. For motility: Gut motility. For oestrogen metabolism pathways: Beta-glucuronidase.
Cycle-related symptom and motility patterns
| Phase | Hormone context | Common gut pattern |
|---|---|---|
| Follicular (post-menses) | Rising oestrogen | Often easiest bowel habit |
| Ovulation | LH surge | Variable |
| Luteal | Progesterone dominant | Slower transit → constipation, bloating |
| Menses | Prostaglandins | Uterine and bowel cramping; diarrhoea in some |
Progesterone relaxes smooth muscle, including colonic muscle, which is one reason IBS-C symptoms worsen premenstrually. Pain sensitivity also fluctuates with oestrogen in some visceral pain models.
Hormonal contraception (combined pill, progestin-only) suppresses ovulation and alters bleeding patterns; microbiome studies show compositional differences vs non-users in some cohorts (Valdes et al., 2018, population association context). The clinical implication is not to change contraception from a stool PDF, it is to note pill use when interpreting a snapshot.
| Symptom pattern | Routing |
|---|---|
| Predictable premenstrual bloating + constipation | Motility + cycle diary before aggressive FODMAP |
| Pain with menses + deep dyspareunia | Consider gynaecology, endometriosis overlap |
| New bleeding after menopause | Clinical urgency, not microbiome-first |
Pregnancy and postpartum (see also pediatric page)
Pregnancy slows transit (progesterone), increases heartburn (mechanical + sphincter relaxation), and shifts stool microbiota toward states that do not match adult optimal ranges on vendor dashboards. Postpartum recovery mixes sleep loss, antibiotics, and dietary change.
Do not use adult report supplement appendices in pregnancy without obstetric sign-off (Pediatric and pregnancy). Fibre for constipation is common; low-FODMAP elimination is not automatic.
Menopause and gut symptoms
Perimenopause, irregular cycles before cessation, often coincides with IBS symptom flares in clinic populations. Proposed mechanisms include oestrogen withdrawal effects on visceral sensitivity, sleep disruption, and weight change, not a single microbial signature.
| Observation | Interpretation limit |
|---|---|
| Cross-sectional ↓ diversity post-menopause | Confounded by age, diet, medications |
| HRT and microbiome studies | Small; heterogeneous formulations |
| Online “oestrogen gut axis” kits | Pathway inference ≠ hormone dosing guidance |
Menopause HRT decisions follow cardiovascular, bone, and symptom guidelines, not beta-glucuronidase percentiles on stool (Beta-glucuronidase). Elevated bacterial β-glucuronidase activity may increase deconjugation of oestrogen metabolites in models; human clinical utility of stool testing for HRT titration is not established.
Endometriosis vs IBS overlap
Endometriosis and IBS co-occur frequently; symptoms include bloating, painful defecation, and cyclical abdominal pain. Rome IBS criteria can be met alongside endometriosis, treating one does not exclude the other.
| Feature | Suggests more gynaecology workup |
|---|---|
| Cyclical pain outside menses | Endometriosis |
| Deep dyspareunia | Endometriosis |
| Family history endometriosis | Higher pre-test probability |
| Alarm GI features | Gastroenterology first (Red flags) |
A microbiome report does not rule in or out endometriosis. Laparoscopy remains diagnostic gold standard where indicated; stool is adjunct at best.
Low-FODMAP diet may reduce bloating in IBS-comorbid endometriosis but does not treat implants. Combined care (gynaecology + dietitian) beats taxon-targeted supplements.
How reports mislead in women’s health context
| Report line | Common over-read |
|---|---|
| Beta-glucuronidase high | ”Oestrogen dominance” → buy supplements |
| Low diversity | ”Hormonal dysbiosis” |
| Low Lactobacillus | Vaginal health extrapolation from stool |
| Dysbiosis flag | Change contraception or HRT |
Stool ecology reflects diet, medications, and geography of the colon, it is not a hormone panel. Dysbiosis labels lack standard cut-offs across vendors.
Retesting tip: if symptoms are cycle-tracked, collect stool at the same cycle phase months apart and log pill/HRT use (Retesting over time).
What not to conclude
- Cycle-related symptom swings do not prove dysbiosis on a static report.
- Beta-glucuronidase scores do not guide HRT or contraceptive choice.
- Blog “hormonal gut cleanse” protocols lack RCT support comparable to low-FODMAP in IBS.
- Endometriosis cannot be excluded because a report looks “balanced.”